Alexander E Hoetink
Overview
Explore the profile of Alexander E Hoetink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoetink A, Kaldenbach S, Lieftink A, Versnel H, Stokroos R
Front Neurosci
. 2024 Dec;
18:1451741.
PMID: 39697775
Introduction: The results from different Cochrane studies justify considerable professional equipoise concerning different treatment options for tinnitus. In case of professional equipoise, Shared Decision Making (SDM) is an indispensable tool...
2.
Veltman J, Maas M, Beijk C, Groenhuis A, Versnel H, Vissers C, et al.
Trends Hear
. 2023 Sep;
27:23312165231198368.
PMID: 37697865
A cochlear implant (CI) is a prosthesis that allows people with severe to profound hearing loss to understand speech in quiet settings. However, listening to music presents a challenge to...
3.
Smit D, Bakker M, Abdellaoui A, Hoetink A, Vulink N, Denys D
Front Neurosci
. 2023 Feb;
16:971752.
PMID: 36760791
Introduction: People with misophonia experience strong negative emotional responses to sounds and associated stimuli-mostly human produced-to an extent that it may cause impairment in social functioning. The exact nature of...
4.
Diepstraten F, Wiersma J, Schoot R, Knops R, Zuur C, Meijer A, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497230
Purpose: The frequency and patterns of HL in a HNRMS survivor cohort were investigated. A dose-effect relationship between the dose to the cochlea and HL was explored. Methods: Dutch survivors...
5.
Diepstraten F, Meijer A, van Grotel M, Plasschaert S, Hoetink A, Fiocco M, et al.
JMIR Res Protoc
. 2022 Apr;
11(4):e34297.
PMID: 35389352
Background: Some children with central nervous system (CNS) and solid tumors are at risk to develop ototoxicity during treatment. Up to now, several risk factors have been identified that may...
6.
Meijer A, van den Heuvel-Eibrink M, Brooks B, Am Zehnhoff-Dinnesen A, Knight K, Freyer D, et al.
JAMA Oncol
. 2021 Aug;
7(10):1550-1558.
PMID: 34383016
Importance: Ototoxicity is an irreversible direct and late effect of certain childhood cancer treatments. Audiologic surveillance during therapy as part of the supportive care pathway enables early detection of hearing...